The Galactosemia Podcast podkast

Why BridgeBio Stopped Galactosemia Gene Therapy

0:00
18:34
Do tyłu o 15 sekund
Do przodu o 15 sekund

BridgeBio recently stopped their research and development of gene therapy for Galactosemia. This came as a shock to many of us. I talked to the CEO of BridgeBio on the phone, and in this episode I report back what he told me. 

Więcej odcinków z kanału "The Galactosemia Podcast"